Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Research Articles

Original Research
Study Among Radiology Doctors to Assess Their Opinion of Abbreviations Used in the Field of Interventional Radiology
09/26/2024
Medical abbreviations play a vital role in the work and research that goes on in a hospital. However, there can be a certain amount of confusion associated with their use. The authors conducted a survey among radiology doctors to assess their...
Medical abbreviations play a vital role in the work and research that goes on in a hospital. However, there can be a certain amount of confusion associated with their use. The authors conducted a survey among radiology doctors to assess their...
Medical abbreviations play a...
09/26/2024
Vascular Disease Management
Original Research
The Impact of Early Vascular Simulation Training in Medical School Education
08/19/2024
This study evaluates the efficacy of vascular surgery simulation training in learning surgical skills, improving readiness for clinical rotations or fourth-year sub-internships, and capturing early interest in surgical specialties.
This study evaluates the efficacy of vascular surgery simulation training in learning surgical skills, improving readiness for clinical rotations or fourth-year sub-internships, and capturing early interest in surgical specialties.
This study evaluates the...
08/19/2024
Vascular Disease Management
Original Research
Suture-Based Vascular Closure Device Failure: A Case Series Analysis
06/17/2024

Rohit Mehra, DrNB1; Vikram Patra, Mch2; Sushma Manral, MD3; D Dinesh, MS4

1Department of Vascular Surgery, Command Hospital (Southern Command),  Pune, India; 2Military Hospital, Meerut, Uttar Pradesh, India; 3Department of Radiodiagnosis, Dr NY Tasgaonkar Medical College, Karjat, Maharashtra, India; 4Department of General Surgery, Armed Forces Medical College, Pune, India
 

Rohit Mehra, DrNB1; Vikram Patra, Mch...
Failure of an SBVCD is an independent predictor of vascular complications and a leading cause of morbidity. This collection of cases illustrates the failure of SBVCDs, including the associated challenges, management strategies, and outcomes.
Failure of an SBVCD is an independent predictor of vascular complications and a leading cause of morbidity. This collection of cases illustrates the failure of SBVCDs, including the associated challenges, management strategies, and outcomes.
Failure of an SBVCD is an...
06/17/2024
Vascular Disease Management
Original Research
Mechanical and Pharmacological Treatment of Symptomatic Acute Portomesenteric Venous Thrombosis Through a TIPS Tract
10/30/2023
The authors evaluate the technical feasibility, long-term patency rate, and clinical outcome in patients who presented with symptomatic acute portomesenteric thrombosis and were treated with mechanical thrombectomy and pharmacological...
The authors evaluate the technical feasibility, long-term patency rate, and clinical outcome in patients who presented with symptomatic acute portomesenteric thrombosis and were treated with mechanical thrombectomy and pharmacological...
The authors evaluate the...
10/30/2023
Vascular Disease Management
Original Research
Acute Limb Ischemia in Patients With COVID-19
06/19/2023
Although the link between COVID-19 and ALI has been established, the particularities of the patients remain poorly described and their management not codified because of its emergent character.
Although the link between COVID-19 and ALI has been established, the particularities of the patients remain poorly described and their management not codified because of its emergent character.
Although the link between...
06/19/2023
Vascular Disease Management
Original Research
Cost Analysis Study of Patients Treated With Percutaneous Coronary Intervention
06/19/2023
This single-center, prospective, cost-analysis study aimed to estimate the total procedural cost of PCI in Greece.
This single-center, prospective, cost-analysis study aimed to estimate the total procedural cost of PCI in Greece.
This single-center, prospective,...
06/19/2023
Vascular Disease Management
Original Research
The Current U.S. Prevalence of Peripheral Arterial Disease
04/20/2023
This study calculated a more accurate 2020 PAD prevalence employing the Diabetes Method and to compare PAD prevalence by this method with those of the Criqui/PARTNERS and Nehler methods for 1995 and for the 2010 to 2030 period.
This study calculated a more accurate 2020 PAD prevalence employing the Diabetes Method and to compare PAD prevalence by this method with those of the Criqui/PARTNERS and Nehler methods for 1995 and for the 2010 to 2030 period.
This study calculated a more...
04/20/2023
Vascular Disease Management
Original Research
Acute Limb Ischemia as a Complication of COVID-19
03/16/2023
One of the many complications of COVID-19 is blood hypercoagulability, which can result in acute limb ischemia (ALI). This study was conducted to present ALI as a complication of hypercoagulability caused by COVID-19 in a hospital in...
One of the many complications of COVID-19 is blood hypercoagulability, which can result in acute limb ischemia (ALI). This study was conducted to present ALI as a complication of hypercoagulability caused by COVID-19 in a hospital in...
One of the many complications of...
03/16/2023
Vascular Disease Management
Original Research
Examining Sex-Based Differences Among Individuals With Peripheral Arterial Disease in Southwest Louisiana: A Secondary Data Analysis
02/16/2023
Exploring the relationship between sex and determinants of PAD and symptom severity, treatments offered, and outcomes.
Exploring the relationship between sex and determinants of PAD and symptom severity, treatments offered, and outcomes.
Exploring the relationship...
02/16/2023
Vascular Disease Management
Original Research
Chemoport Implantation by Interventional Radiologists: A Retrospective Clinical Study
01/19/2023
The purpose of this long-term retrospective study is to report a tertiary care center experience on the placement of chemoports by interventional radiologists, including technical success rates, complication rates, and clinical outcomes.
The purpose of this long-term retrospective study is to report a tertiary care center experience on the placement of chemoports by interventional radiologists, including technical success rates, complication rates, and clinical outcomes.
The purpose of this long-term...
01/19/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement